BRIEF published on 11/13/2025 at 23:35, 8 months 21 days ago Medicure to Announce Q3 2025 Financial Results on November 20 Financial Results Conference Call Medicure Inc. U.S. Pharmaceuticals AGGRASTAT® And ZYPITAMAG®
PRESS RELEASE published on 11/13/2025 at 23:30, 8 months 21 days ago Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025 Medicure Inc. will present Financial Results for Q3 2025 on November 20, 2025, focusing on pharmaceutical development and commercialization in the U.S. market Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 08/20/2025 at 23:35, 11 months 15 days ago Medicure Reports Q2 2025 Financial Results Financial Results Net Loss Net Revenue Research Investment Pharmaceutical Business
PRESS RELEASE published on 08/20/2025 at 23:30, 11 months 15 days ago Medicure Reports Financial Results for Quarter Ended June 30, 2025 Medicure Inc. reports Q2 2025 financial results, including increased revenue from Marley Drug and ZYPITAMAG(R), and enhanced adjusted EBITDA. Find full details at www.medicure.com Financial Results Medicure Inc. Marley Drug ZYPITAMAG Q2 2025
BRIEF published on 08/18/2025 at 23:35, 11 months 17 days ago Medicure to Announce Q2 2025 Financial Results via Conference Call Financial Results Conference Call Pharmaceuticals Medicure Q2 2025
PRESS RELEASE published on 08/18/2025 at 23:30, 11 months 17 days ago Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025 Medicure Inc. to present Financial Results for Q2 2025 on August 21, 2025 via conference call. Operations and products focus detailed Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 06/17/2025 at 23:05, 1 year 1 month ago Medicure Finalizes Acquisition of West Olympia Pharmacy Acquisition Revenue Growth Pharmaceuticals Pharmacy Medicure
PRESS RELEASE published on 06/17/2025 at 23:00, 1 year 1 month ago Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy Medicure Inc. announces acquisition of West Olympia Pharmacy Inc., further boosting direct-to-consumer pharmacy business and sales of ZYPITAMAG(R) and BRENZAVVY(R) Acquisition Medicure Inc. Pharmacy Business ZYPITAMAG(R) BRENZAVVY(R)
BRIEF published on 05/21/2025 at 23:05, 1 year 2 months ago Medicure Announces Q1 2025 Financial Results and Director Election Outcomes Net Loss Director Election Medicure Financial Results AGGRASTAT Sales Decline Pharmacy Revenue
PRESS RELEASE published on 05/21/2025 at 23:00, 1 year 2 months ago Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results Medicure Inc. reports Q1 2025 results with $5.5M net revenue, elects directors, and details financial performance. AGGRASTAT and ZYPITAMAG sales analyzed Medicure Inc. Net Revenue AGGRASTAT ZYPITAMAG Q1 2025 Results
Published on 08/04/2026 at 22:30, 2 hours 12 minutes ago Nextech3D.ai Provides Update on Acquisition of Remaining ARway Shares
Published on 08/04/2026 at 16:25, 8 hours 17 minutes ago ACCESS Newswire to Host Second Quarter Earnings Conference Call on August 11, 2026
Published on 08/04/2026 at 15:00, 9 hours 42 minutes ago Infield Minerals Expands Land Position at the Kings Canyon Gold Project in Utah
Published on 08/04/2026 at 15:00, 9 hours 42 minutes ago Secure Blockchain's Agentic Solutions Signs First Enterprise AI Customer
Published on 08/04/2026 at 22:03, 2 hours 38 minutes ago #FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised
Published on 08/04/2026 at 22:01, 2 hours 40 minutes ago EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises its earnings guidance for fiscal year 2026 due to strong operational business performance
Published on 08/04/2026 at 20:05, 4 hours 36 minutes ago Hard Rock Cafe and Coca-Cola® Launch Hard Rock Rising Music Competition for Emerging Artists
Published on 08/04/2026 at 19:39, 5 hours 2 minutes ago EQS-Adhoc: Basler AG financial results for the first 6 months of 2026: Strong business performance in the first half of the year; company raises its 2026 forecast once again
Published on 08/04/2026 at 18:32, 6 hours 9 minutes ago Total number of voting rights and shares making up the share capital at July 31, 2026
Published on 08/04/2026 at 17:45, 6 hours 57 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 08/04/2026 at 16:00, 8 hours 42 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 08/04/2026 at 08:15, 16 hours 27 minutes ago Covivio - Conditions of availability of the 2026 Half-year report
